Skip to main content

Rolling Action Plan – our chemical evaluations list

The Rolling Action Plan lists our current and recently completed chemical evaluations. The Rolling Action Plan forms part of our approach to protecting human health and the environment.

Decorative image

 

What is the Rolling Action Plan?

The Rolling Action Plan is our work plan for prioritising chemicals for evaluation, which are selected based on the outcomes of our Evaluation Selection Analysis (ESA) process.

The plan lists our proposed, ongoing and recently completed chemical evaluations. It doesn't include evaluations initiated for chemicals under a current assessment certificate. 

Our Evaluations Roadmap describes our strategic approach to protect human health and the environment by providing information and recommendations about managing the risks that arise from introducing and using industrial chemicals. By prioritising chemicals on the Inventory, our evaluations are more risk-proportionate, timely and targeted.

For each entry, the Rolling Action Plan includes the: 

  • subject of the evaluation – typically the chemical name or chemical group name
  • reason for the evaluation
  • an estimated evaluation end date
  • focus of the evaluation – chemical identity, and human health or the environment (or both)
  • amendments to the list of our initiated evaluations.

The publication of the subject, reason and time period within which the evaluation will be conducted satisfies the requirements of the Industrial Chemicals Act 2019 for initiating an evaluation. Listing the evaluation on the RAP means that it has commenced. An estimated time period for conducting the evaluation is provided in the table below.

During an Evaluation Selection Analysis (ESA) process we will identify chemicals that may pose a risk to human health and/or the environment. We will also identify chemicals that are unlikely to require further regulation to manage risks based on their human health and environmental hazards and exposures. This will allow us to publish Evaluation Statements for these chemicals and provide the rationale for not undertaking more detailed evaluations.

When do we update the Rolling Action Plan? 

Generally, we will update the Rolling Action Plan after publishing our evaluations. We publish a notice on our website when we update it. 

We will add details of newly initiated evaluations. Other changes to the rolling action plan may include amendments to the: 

  • evaluation subject
  • estimated evaluation end date
  • reason for the evaluation

We may need to update the Rolling Action Plan at other times. If we do, we’ll consult with interested parties and publish a notice on our website. These updates can happen for many reasons, including:

  • an adverse event that warrants a chemical evaluation
  • a stakeholder request to evaluate a chemical has been prioritised through ESA process
  • a post-assessment obligation leads to an evaluation
  • we are informed that new information will become available for the chemical that warrants a chemical evaluation

The identified chemicals covered by the subject of the evaluation may change as the evaluation progresses due to new information becoming available.

Completed evaluations remain on the Rolling Action Plan until the next set of evaluations are published. 

Note: Please contact us if you have any information about any chemical listed on the Rolling Action Plan.

Rolling Action Plan

Evaluations under consultation, in progress and recently completed

We publish and maintain the following information as part of the Rolling Action Plan. 

  1. Lists of evaluations that are in progress, currently open for public consultation or recently completed. Each evaluation could be for a single chemical or a group of chemicals.
  2. Downloadable spreadsheet of chemicals that are covered by an evaluation that is in progress, currently open for public consultation, or recently completed. These chemicals can change during the course of the evaluation if new information becomes available.

Download

Evaluations under public consultation

The following evaluations are open for consultation until 27 May 2024 - go to our consultation page, where you'll also be able to download drafts.
EVA IDSubject of evaluationEvaluation estimated end dateFocusAmendments to RAP
EVA00105Water-soluble zinc salts30/06/2024
 
EnvironmentThe timeframe for completion of this evaluation was extended to enable provision of information to inform our risk assessment. 
EVA001262-Ethylhexyl phosphates30/06/2024
 
Environment-
EVA00130Acrylates and methacrylates based on bisphenol A (BPA)31/12/2024Health-
EVA00131Alkoxysilane ethylenediamine and polyamine derivatives
 
30/06/2024Health-
EVA00135Benzenesulfonic acid, dodecyl-, compound with 4,4-dimethyloxazolidine (1:1)
 
30/06/2024
 
Health-
EVA00136Benzoic acid, 2-hydroxy-, methyl ester (methyl salicylate)
 
30/06/2024
 
Health-
EVA00141Cyanoacrylates
 
30/6/2024Health-
EVA00143Environmental fate and effects of zinc ions
 
30/6/2024Environment-
EVA00146Medium and long chain alkyl sulfates
 
31/12/2024Health and environment-
EVA00150Salicylic acid and its salts30/6/2024
 
Health and environment-
EVA00154Hexamine and related chemicals
 
31/12/2024Environment-
EVA00155Chemicals that are unlikely to require further regulation to manage risks to environment
 
31/12/2024Environment-
EVA00156Chemicals that are unlikely to require further regulation to manage risks to human health
 
31/12/2024
 
Health-
EVA00157Chemicals not considered for in depth evaluation – Not commercially active in Australia
 
31/12/2024
 
Health and environment-

Evaluations in progress

EvA IDSubject of evaluationReason for evaluationEvaluation estimated end dateFocusAmendments to RAP
EVA001221H-Benzotriazole and its mono-substituted derivativesEvaluation Selection Analysis indicated a potential human health risk.31/12/2024Health-
EVA00147Phenolic benzotriazolesEvaluation Selection Analysis indicated a potential human health risk.31/12/2024Health-
EVA00151Tellurium and its inorganic compoundsEvaluation Selection Analysis indicated a potential human health risk.31/12/2024Health-
EVA00153Extracts and essential oils primarily composed of methyl salicylate 
 
Evaluation Selection Analysis indicated a potential human health risk.31/12/2024Health-

 

Recently completed evaluations

Evaluation IDSubjectReason for evaluationTimeframeFocusStatus Reason
EVA000411,4:7,10-Dimethanodibenzo[a,e]cyclooctene, 1,2,3,4,7,8,9,10,13,13,14,14-dodecachloro-1,4,4a,5,6,6a,7,10,10a,11,12,12a-dodecahydro- (Dechlorane Plus)Evaluation Selection Analysis indicated a potential human health and environmental risk.30/06/2023Health and EnvironmentCompleted
EVA00093Chemicals not considered for in depth evaluation – Not commercially active in AustraliaEvaluation is needed to provide information on human health and environmental risks.30/06/2023Health and EnvironmentCompleted
EVA00096BenzaldehydeEvaluation is needed to provide information on human health risks.30/06/2023HealthCompleted
EVA00097Aniline and its saltsEvaluation Selection Analysis indicated a potential human health risk.30/06/2023HealthCompleted
EVA00098Benzene, 1-chloro-4-(trifluoromethyl)-Evaluation Selection Analysis indicated a potential human health risk.30/06/2023HealthCompleted
EVA00099Peroxide, bis(1-methyl-1-phenylethyl) (dicumyl peroxide)Evaluation Selection Analysis indicated a potential human health risk.30/06/2023HealthCompleted
EVA00102Water soluble arsenic compoundsEvaluation is needed to provide information on environmental risks.30/06/2023EnvironmentCompleted
EVA00103Tocopherols and their salts and estersEvaluation Selection Analysis indicated a potential human health risk.30/06/2023HealthCompleted
EVA00104Cresyl phosphates and xylyl phosphatesEvaluation Selection Analysis indicated a potential environmental risk.30/06/2023EnvironmentCompleted
EVA00108Triphenyl phosphate and diphenyl phosphateEvaluation Selection Analysis indicated a potential environmental risk.30/06/2023EnvironmentCompleted
EVA00109PhenylenediaminesEvaluation Selection Analysis indicated a potential environmental risk.30/06/2023EnvironmentCompleted
EVA00111Cyclohexanamine, 4,4'-methylenebis[2-methyl-Evaluation Selection Analysis indicated a potential human health risk.30/06/2023HealthCompleted
EVA00113Propyl and butyl phenolsEvaluation Selection Analysis indicated a potential human health risk.30/06/2023HealthCompleted
EVA00115Polymers with pendant acrylatesEvaluation Selection Analysis indicated a potential human health risk.30/06/2023HealthCompleted
EVA00117Alkyl diphenyl oxide sulfonatesEvaluation Selection Analysis indicated a potential human health risk.30/06/2023HealthCompleted
EVA00119Chemicals that are unlikely to require further regulation to manage risks to environmentEvaluation is needed to provide information on environmental risks.31/12/2023EnvironmentCompleted
EVA00120Chemicals that are unlikely to require further regulation to manage risks to human healthEvaluation is needed to provide information on human health risks.31/12/2023HealthCompleted
EVA00121Acetoin, cinnamaldehyde, diethylene glycol and ethylene glycol with end use in non-nicotine e-cigarettes (vaping products)Evaluation Selection Analysis indicated a potential human health risk.31/12/2023HealthCompleted
EVA001231-Propanesulfonic acid, 2-hydroxy-3-(2-propenyloxy)-, monosodium saltEvaluation Selection Analysis indicated a potential human health risk.30/06/2024HealthCompleted
EVA001241-Propene, 3-chloro-2-methyl-Evaluation Selection Analysis indicated a potential human health risk.30/06/2024HealthCompleted
EVA001252-Butanone, oxime (MEKO)New information is available about human health risks.30/06/2024HealthCompleted
EVA001272-Methoxyethyl methacrylate and 2-ethoxyethyl methacrylateEvaluation Selection Analysis indicated a potential human health risk.30/06/2024HealthCompleted
EVA001282-Propenamide, N,N'-methylenebis- (N,N'-methylenebisacrylamide)Evaluation Selection Analysis indicated a potential human health risk.30/06/2024HealthCompleted
EVA001292-Propenoic acid, 2-methyl-, 2-ethylhexyl ester (ethylhexyl methacrylate)Evaluation Selection Analysis indicated a potential human health risk.30/06/2024HealthCompleted
EVA00132Alkoxysilanes substituted with 2-ethoxyethanolEvaluation Selection Analysis indicated a potential human health risk.30/06/2024HealthCompleted
EVA00133Benzenamine, N-phenyl-Evaluation Selection Analysis indicated a potential human health risk.30/06/2024HealthCompleted
EVA00134Benzene, 1-methoxy-4-nitro-Evaluation Selection Analysis indicated a potential human health risk.30/06/2024HealthCompleted
EVA00137Chlorendic acid and chlorendic anhydrideEvaluation Selection Analysis indicated a potential human health risk.30/06/2024HealthCompleted
EVA00138Chemicals not considered for in depth evaluation – Not commercially active in AustraliaEvaluation is needed to provide information on human health and environmental risks.30/06/2024Health and EnvironmentCompleted
EVA00139Chemicals that are unlikely to require further regulation to manage risks to environmentEvaluation is needed to provide information on environmental risks.30/06/2024EnvironmentCompleted
EVA00140Chemicals that are unlikely to require further regulation to manage risks to human healthEvaluation is needed to provide information on human health risks.30/06/2024HealthCompleted
EVA00142Cyclohexanamine, 4,4'-methylenebis-Evaluation Selection Analysis indicated a potential human health risk.30/06/2024HealthCompleted
EVA00144Fluorescent Brightener 71 and related chemicalsEvaluation Selection Analysis indicated a potential environmental risk.30/06/2024EnvironmentCompleted
EVA00145Glycidyl neodecanoate and glycidyl tert-decanoateEvaluation Selection Analysis indicated a potential human health risk.30/06/2024HealthCompleted
EVA00148Morpholine, 4-(1-oxo-2-propenyl)- (acryloyl morpholine)Evaluation Selection Analysis indicated a potential human health risk.30/06/2024HealthCompleted
EVA00149Hydroxymethylated imidazolidinonesEvaluation Selection Analysis indicated a potential environmental risk.30/06/2024EnvironmentCompleted
EVA00152Tetrahydrofurfuryl acrylate and tetrahydrofurfuryl methacrylateEvaluation Selection Analysis indicated a potential human health risk.30/06/2024HealthCompleted
Last updated
Was this page helpful?
For broken links or technical issues, please provide as much detail as possible. Do not include your name, email address and other personal or commercially sensitive information.

Keep informed with updates